Functionally, co-treatment with nicotine and PKI, 4-MU, or VEGF antibodies reduced cell viability and increased apoptosis, indicating that targeting PKA-dependent VEGF regulation may sensitize NSCLC cells to growth inhibition. This evidence concerns the gene VEGFA and non-small cell lung carcinoma.